Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Descripción

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

A Reappraisal of the Antiviral Properties of and Immune Regulation through Dietary Phytochemicals

Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants - ScienceDirect

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

Advances in natural product anti-coronavirus research (2002-2022), Chinese Medicine

SARS-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts - ScienceDirect

In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal

Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

Frontiers Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand

€ 3.99EUR
puntaje 5(787)
En stock
Continuar reservando